Ticker Scorecard - TARS Basics Company: Tarsus Pharmaceuticals, Inc. Common Stock IPO Date: October 12, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.83B Activated in VL: True Average Daily Range Avg Daily Range: $0.71 | 2.79% Avg Daily Range (30 D): $1.33 | 2.60% Avg Daily Range (90 D): $1.17 | 2.43% Institutional Daily Volume Avg Daily Volume: .23M Avg Daily Volume (30 D): .46M Avg Daily Volume (90 D): .54M Trade Size Avg Trade Size (Sh.): 62 Avg Trade Size (Sh.) (30 D): 47 Avg Trade Size (Sh.) (90 D): 55 Institutional Trades Total Inst.Trades: 953 Avg Inst. Trade: $2.62M Avg Inst. Trade (30 D): $2.4M Avg Inst. Trade (90 D): $3.05M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.31M Avg Closing Trade (30 D): $3.46M Avg Closing Trade (90 D): $3.6M Avg Closing Volume: 73.58K     News Feb 20, 2025 @ 10:00 PM Tarsus to Report Fourth Quarter and Full-Year 2024... Source: N/A Jan 30, 2025 @ 10:00 PM Tarsus to Participate in Upcoming Investor Confere... Source: N/A Sep 12, 2024 @ 2:00 PM Questex’s Fierce Pharma Announces the 2024 ... Source: Globe Newswire Aug 28, 2024 @ 9:00 PM Tarsus to Participate in Fireside Chat at the 2024... Source: N/A May 29, 2024 @ 9:00 PM Tarsus to Participate in Upcoming Investor Confere... Source: Tarsus Pharmaceuticals, Inc Financials   TTM Q3 2024 Q2 2024 Basic EPS $-3.77 $-.61 $-.88 Diluted EPS $-3.77 $-.61 $-.88 Revenue $ 129.62M $ 48.12M $ 40.81M Gross Profit $ $ $ Net Income / Loss $ -134.34M $ -23.42M $ -33.29M Operating Income / Loss $ -140.6M $ -25.16M $ -33.3M Cost of Revenue $ $ $ Net Cash Flow $ -50.46M $ -4.89M $ -12.61M PE Ratio